Literature DB >> 7009152

Purification and characterization of insulin-degrading enzyme from pig skeletal muscle.

K Yokono, Y Imamura, K Shii, H Sakai, S Baba.   

Abstract

An enzyme capable of degrading insulin was purified from pig skeletal muscle and studied for its characteristics. Purification of the enzyme was successfully achieved by a combination of ammonium sulfate precipitation, chromatography of Bio-Gel P-200 and DEAE-cellulose, and, finally, ampholine isoelectrofocusing. The enzyme obtained showed 741-fold purification in its activity and a single band on polyacrylamide gel electrophoresis. The purified enzyme degraded insulin proteolytically and was sulfhydryl dependent. The Km for insulin was 70 nM. Proinsulin behaved as a competitive inhibitor for insulin degradation; its Ki was 320 nM. Glucagon was also proteolytically degraded, whereas number of other peptides, including A and B chains of insulin, were not appreciably affected by this enzyme. The molecular weight of the enzyme was estimated to be 135,000 by gel filtration on Sephadex G-200 and 60,000 by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. This enzyme and lysosomal enzymes extracted from rat liver were shown to be different, judging from their optimal pH for insulin degradation and substrate specificity. These studies demonstrate the presence of an insulin-degrading enzyme in pig skeletal muscle and suggest that this enzyme is identical to rat insulin protease in most of its biochemical properties.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7009152     DOI: 10.1210/endo-108-4-1527

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  8 in total

1.  Inhibition of insulin degradation by hepatoma cells after microinjection of monoclonal antibodies to a specific cytosolic protease.

Authors:  K Shii; R A Roth
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

2.  Possible role of cell surface insulin degrading enzyme in cultured human lymphocytes.

Authors:  S Yaso; K Yokono; J Hari; K Yonezawa; K Shii; S Baba
Journal:  Diabetologia       Date:  1987-01       Impact factor: 10.122

3.  Preparation and characterization of novel substrates of insulin proteinase (EC 3.4.99.45).

Authors:  R C Werlen; R E Offord; K Rose
Journal:  Biochem J       Date:  1994-09-15       Impact factor: 3.857

4.  Insulin degrading enzyme activity and insulin binding of erythrocytes in normal subjects and Type 2 (non-insulin-dependent) diabetic patients.

Authors:  E Standl; H J Kolb
Journal:  Diabetologia       Date:  1984-07       Impact factor: 10.122

5.  Insulin-degrading enzyme in a human colon adenocarcinoma cell line (Caco-2).

Authors:  J P Bai; M J Hsu; W T Shier
Journal:  Pharm Res       Date:  1995-04       Impact factor: 4.200

6.  Evidence for insulin degradation by muscle and fat tissue in an insulin resistant diabetic patient.

Authors:  G F Maberly; G A Wait; J A Kilpatrick; E G Loten; K R Gain; R D Stewart; C J Eastman
Journal:  Diabetologia       Date:  1982-10       Impact factor: 10.122

7.  Transepithelial transport of insulin: I. Insulin degradation by insulin-degrading enzyme in small intestinal epithelium.

Authors:  J P Bai; L L Chang
Journal:  Pharm Res       Date:  1995-08       Impact factor: 4.200

8.  Cleavage of membrane secretory component to soluble secretory component occurs on the cell surface of rat hepatocyte monolayers.

Authors:  L S Musil; J U Baenziger
Journal:  J Cell Biol       Date:  1987-06       Impact factor: 10.539

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.